Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.

Yang C, Sun L, Zhang L, Zhou L, Zhao M, Peng Y, Niu D, Li Z, Huang X, Kang Q, Jia L, Lai J, Cao D.

Am J Surg Pathol. 2018 Feb;42(2):160-171. doi: 10.1097/PAS.0000000000000951.

PMID:
28914716
2.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
3.

SATB2 Shows Different Profiles Between Appendiceal Adenocarcinomas Ex Goblet Cell Carcinoids and Appendiceal/Colorectal Conventional Adenocarcinomas: An Immunohistochemical Study With Comparison to CDX2.

Yang C, Sun L, Zhang L, Zhou L, Niu D, Cao W, Li Z, Huang X, Kang Q, Jia L, Platik M, Liu X, Lai J, Cao D.

Gastroenterology Res. 2018 Jun;11(3):221-230. doi: 10.14740/gr1015w. Epub 2018 May 31.

4.

Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.

Li Z, Roth R, Rock JB, Lehman A, Marsh WL, Suarez A, Frankel WL.

Am J Clin Pathol. 2017 May 1;147(5):484-491. doi: 10.1093/ajcp/aqx023.

6.

Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Vang R, Gown AM, Wu LS, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.

Mod Pathol. 2006 Nov;19(11):1421-8. Epub 2006 Sep 15.

7.

The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.

Perez Montiel D, Arispe Angulo K, Cantú-de León D, Bornstein Quevedo L, Chanona Vilchis J, Herrera Montalvo L.

Ann Diagn Pathol. 2015 Aug;19(4):249-52. doi: 10.1016/j.anndiagpath.2015.05.004. Epub 2015 May 21.

PMID:
26059401
8.

Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.

Giannico GA, Gown AM, Epstein JI, Revetta F, Bishop JA.

Hum Pathol. 2017 Sep;67:152-159. doi: 10.1016/j.humpath.2017.07.002. Epub 2017 Jul 13.

PMID:
28711650
9.
10.

Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.

Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C.

Int J Gynecol Pathol. 2016 May;35(3):191-208. doi: 10.1097/PGP.0000000000000238.

PMID:
26535987
11.
12.

SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

Li Z, Yuan J, Wei L, Zhou L, Mei K, Yue J, Gao H, Zhang M, Jia L, Kang Q, Huang X, Cao D.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7072-82. eCollection 2015.

13.
14.

Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.

McCluggage WG, Young RH.

Am J Surg Pathol. 2008 Sep;32(9):1373-9. doi: 10.1097/PAS.0b013e31816b18c1.

PMID:
18670351
15.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
16.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M.

Mod Pathol. 2019 Jun 25. doi: 10.1038/s41379-019-0302-0. [Epub ahead of print]

PMID:
31239549
17.

[Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].

Lyn J, Wang Y, Wang F, Shen M, Zhou X.

Zhonghua Bing Li Xue Za Zhi. 2015 Aug;44(8):578-81. Chinese.

PMID:
26705182
19.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18.

PMID:
19926591
20.

Neuroendocrine Markers Insulinoma-Associated Protein 1, Chromogranin, Synaptophysin, and CD56 Show Rare Positivity in Adenocarcinoma Ex-Goblet Cell Carcinoids.

Yang C, Gonzalez I, Zhang L, Cao D.

Gastroenterology Res. 2019 Jun;12(3):120-127. doi: 10.14740/gr1138. Epub 2019 Jun 7.

Supplemental Content

Support Center